Biophytis (EPA:ALBPS) | WebDisclosure

Basculer en Français

11081	Companies
243115	Keywords
171254	Articles
130874	Press releases

Home
Companies
Biophytis

REGULATED PRESS RELEASE

published on 01/21/2025 at 07:00, 1 year 8 months ago

Biophytis et AskHelpU signent un accord de co-développement dans les maladies rares neuromusculaires en Chine
Biophy's et AskHelpU signent un accord de co-développement dans les maladies rares neuromusculaires en Chine. Analyse de l'efficacité du candidat-médicament BIO101 de Biophytis dans la SLA

Maladies Rares Biophy's SLA Co-développement AskHelpU
REGULATED PRESS RELEASE

published on 01/21/2025 at 07:00, 1 year 8 months ago

Biophytis and AskHelpU Sign a Co-Development Agreement in Rare Neuromuscular Diseases in China
Biophy's and AskHelpU sign a co-development agreement for rare neuromuscular diseases in China. The agreement aims to evaluate BIO101's efficacy in ALS, potentially offering a major therapeutic solution for patients

Biophy's ALS AskHelpU Co-development Agreement Neuromuscular Diseases
BRIEF

published on 01/14/2025 at 07:05, 1 year 8 months ago

Biophytis en Négociation Exclusive pour Licencier BIO101 en Chine

Biophytis Négociation Exclusive Chine Pharmaceutique BIO101
BRIEF

published on 01/14/2025 at 07:05, 1 year 8 months ago

Biophytis Enters Exclusive Negotiations for BIO101 in China

Biophytis Age-related Diseases BIO101 Pharmaceutical Partnership China Licensing
REGULATED PRESS RELEASE

published on 01/14/2025 at 07:00, 1 year 8 months ago

Biophytis entre en négociation exclusive avec une société pharmaceutique chinoise pour licencier BIO101
Biophytis entre en négociation exclusive avec une société pharmaceutique chinoise pour licencier BIO101. L'objectif est de co-développer et commercialiser le traitement en Chine

Biophytis Négociation Exclusive BIO101 Co-développement Société Pharmaceutique Chinoise
REGULATED PRESS RELEASE

published on 01/14/2025 at 07:00, 1 year 8 months ago

Biophytis Enters Exclusive Negotiations with a Chinese Pharmaceutical Company to License BIO101
Biophytis enters exclusive negotiations with a Chinese pharmaceutical company to license BIO101 for viral respiratory infections, sarcopenia, and obesity. The potential partnership aims to develop and commercialize the drug in China's growing pharmaceutical market

Biophytis Exclusive Negotiations Chinese Pharmaceutical Company BIO101 License Viral Respiratory Infections
BRIEF

published on 01/08/2025 at 07:05, 1 year 8 months ago

Biophytis obtient des financements pour son programme d'obésité

Investissement Biophytis Refinancement BIO101 Obésité
BRIEF

published on 01/08/2025 at 07:05, 1 year 8 months ago

Biophytis Secures €8.6 Million for Obesity Program

Clinical Development Debt Conversion Obesity Program Biophytis Financing New Investors
REGULATED PRESS RELEASE

published on 01/08/2025 at 07:00, 1 year 8 months ago

Biophytis annonce un nouvel apport en cash et une conversion de dettes pouvant atteindre 8,6 M€ pour financer son programme dans l’obésité
Biophytis annonce un nouvel apport en cash de 2,5 M€ et une conversion de dettes jusqu'à 6,1 M€ pour financer son programme dans l'obésité. Opération de refinancement de 8,6 M€ pour consolider sa structure financière et lancer l'étude de phase 2 OBA aux États-Unis

Biophytis Financement Développement Clinique Opération Financière Obésité
REGULATED PRESS RELEASE

published on 01/08/2025 at 07:00, 1 year 8 months ago

Biophytis Announces New Cash Contribution and Debt Conversion up to €8.6 million to Finance the Obesity Program
Biophytis announces new cash contribution and debt conversion totaling €8.6 million to finance obesity program. Strategic financial transaction strengthens company's financial structure for future development

Biophytis Financial Transaction Debt Conversion Obesity Program Cash Contribution

Accesswire

Published on 09/25/2026 at 00:30, 3 hours 2 minutes ago

Viemed Healthcare Announces Adoption of Automatic Securities Disposition Plan by President Michael Moore
Published on 09/25/2026 at 00:15, 3 hours 17 minutes ago

CoTec Holdings Corp. Announces Extension of Private Placement of Unsecured Convertible Debentures
Published on 09/24/2026 at 22:01, 5 hours 31 minutes ago

Fermi Selects CBRE to Operate and Maintain Its First Data Center
Published on 09/24/2026 at 17:45, 9 hours 47 minutes ago

Jo-Jo Announces Resignation of Director
Published on 09/24/2026 at 14:55, 12 hours 37 minutes ago

Nextech3D.ai Surpasses $1 Million in New Customer Contract Value, Expands AI Software Portfolio with KATE and Grows Multi-Year Enterprise Agreements

View all ACCESSWIRE

EQS Group

Published on 09/25/2026 at 02:45, 46 minutes ago

Huagui Group: un acteur mondial sur deux marchés aquatiques de plus de 100 milliards de RMB, tandis que la racine de lotus de Honghu se classe au premier rang pour sa teneur en antioxydants
Published on 09/25/2026 at 02:45, 46 minutes ago

Huagui Group: A Global Player Across Two RMB100-Billion Aquatic Markets, as Honghu Lotus Root Ranks No. 1 in Antioxidant Content
Published on 09/24/2026 at 20:29, 7 hours 2 minutes ago

EQS-Adhoc: HelloFresh SE expects revenue for Q3 2026 below market expectations and adjusts outlook for the financial year 2026
Published on 09/24/2026 at 19:00, 8 hours 32 minutes ago

HIAG provides a first-hand insight into its strategy and the added value it generates at its Capital Market Day
Published on 09/24/2026 at 18:40, 8 hours 51 minutes ago

EQS-Adhoc: Brockhaus Technologies AG launches public share buyback offer of approx. €90 million for up to 3,592,000 shares

Les Echos

Published on 09/24/2026 at 18:31, 9 hours ago

LNA SANTE : Mise à disposition du rapport financier semestriel 2026
Published on 09/24/2026 at 18:10, 9 hours 22 minutes ago

Financial statements - 30 june 2026
Published on 09/24/2026 at 18:00, 9 hours 32 minutes ago

GUILLEMOT CORPORATION: Availability of the interim financial report to June 30, 2026
Published on 09/24/2026 at 18:00, 9 hours 32 minutes ago

GUILLEMOT CORPORATION : Mise à disposition du rapport financier semestriel au 30 juin 2026
Published on 09/24/2026 at 18:00, 9 hours 32 minutes ago

i2S : Résultats 1er semestre 2026

View all LES ECHOS COMFI WIRE